Immunogenicity of the Inactivated Split-Virion Influenza Vaccine in Renal Transplant Subjects

Clinical trial NCT00606359 · COMPLETED

Trial details

NCT number: NCT00606359
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza Orthomyxoviridae Infections

Start date: 2007-11-01
Primary completion: 2008-02-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.